citalopram Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
663 59729-33-8

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • citalopram
  • nitalapram
  • bonitrile
  • citalopram hydrobromide
A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
  • Molecular weight: 324.40
  • Formula: C20H21FN2O
  • CLOGP: 3.13
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 0
  • TPSA: 36.26
  • ALOGS: -4.74
  • ROTB: 5

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
20 mg O
20 mg P

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 2 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 0.03 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 12 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 2.64 ┬ÁM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
Vd (Volume of distribution) 12 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 4.30 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.20 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 33 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
July 17, 1998 FDA FOREST LABS

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Completed suicide 5265.78 33.06 1402 9191 19632 2327860
Toxicity to various agents 5137.36 33.06 1512 9081 31242 2316250
Drug abuse 2898.51 33.06 783 9810 11243 2336249
Drug interaction 1793.24 33.06 671 9922 28492 2319000
Overdose 1638.55 33.06 569 10024 19338 2328154
Electrocardiogram QT prolonged 1436.24 33.06 413 10180 7401 2340091
Serotonin syndrome 1377.47 33.06 339 10254 3201 2344291
Intentional overdose 1338.91 33.06 426 10167 10895 2336597
Hyponatraemia 1290.63 33.06 431 10162 12894 2334598
Cardio-respiratory arrest 1213.65 33.06 376 10217 8770 2338722
Suicide attempt 1152.11 33.06 380 10213 10902 2336590
Cardiac arrest 925.56 33.06 347 10246 14583 2332909
Respiratory arrest 877.89 33.06 268 10325 5910 2341582
Anxiety 811.81 33.06 384 10209 28975 2318517
Agitation 762.09 33.06 278 10315 10773 2336719
Poisoning 709.11 33.06 191 10402 2629 2344863
Confusional state 643.40 33.06 309 10284 24035 2323457
Suicidal ideation 625.96 33.06 241 10352 10846 2336646
Sopor 617.21 33.06 185 10408 3810 2343682
Intentional self-injury 615.58 33.06 186 10407 3941 2343551
Depression 615.56 33.06 314 10279 27818 2319674
Somnolence 596.00 33.06 290 10303 23195 2324297
Fall 589.24 33.06 364 10229 46735 2300757
Tremor 584.65 33.06 275 10318 20386 2327106
Seizure 514.30 33.06 266 10327 24200 2323292
Foetal exposure during pregnancy 507.13 33.06 170 10423 5082 2342410
Dizziness 499.97 33.06 357 10236 58308 2289184
Vomiting 483.83 33.06 379 10214 71223 2276269
Intentional product misuse 453.59 33.06 183 10410 9306 2338186
Nausea 438.78 33.06 435 10158 111754 2235738
Loss of consciousness 428.81 33.06 216 10377 18551 2328941
Death 426.56 33.06 372 10221 81096 2266396
Exposure during pregnancy 420.00 33.06 235 10358 24984 2322508
Coma 403.17 33.06 166 10427 8890 2338602
Torsade de pointes 399.13 33.06 116 10477 2130 2345362
Mydriasis 387.22 33.06 113 10480 2106 2345386
Drug hypersensitivity 385.57 33.06 279 10314 46364 2301128
Hypotension 385.21 33.06 243 10350 32193 2315299
Headache 365.81 33.06 339 10254 79840 2267652
Accidental overdose 361.32 33.06 123 10470 3849 2343643
Hypokalaemia 361.04 33.06 161 10432 10493 2336999
Restlessness 344.62 33.06 123 10470 4440 2343052
Bradycardia 322.75 33.06 146 10447 9835 2337657
Electrocardiogram QRS complex prolonged 321.28 33.06 84 10509 1018 2346474
Tachycardia 320.26 33.06 170 10423 16239 2331253
Hyperhidrosis 315.81 33.06 165 10428 15257 2332235
Fatigue 295.81 33.06 310 10283 84563 2262929
Insomnia 292.91 33.06 188 10405 25599 2321893
Syncope 285.31 33.06 159 10434 16716 2330776
Ventricular tachycardia 284.63 33.06 96 10497 2915 2344577
Unresponsive to stimuli 281.84 33.06 108 10485 4768 2342724
Medication error 281.60 33.06 115 10478 6016 2341476
Panic attack 277.52 33.06 101 10492 3855 2343637
Depressed level of consciousness 264.17 33.06 117 10476 7487 2340005
Aggression 262.34 33.06 102 10491 4684 2342808
Myoclonus 261.93 33.06 86 10507 2397 2345095
Malaise 246.91 33.06 232 10361 55353 2292139
Condition aggravated 244.96 33.06 183 10410 31796 2315696
Disturbance in attention 238.60 33.06 100 10493 5585 2341907
Exposure via ingestion 234.18 33.06 61 10532 727 2346765
Disorientation 227.61 33.06 100 10493 6272 2341220
Generalised tonic-clonic seizure 223.78 33.06 94 10499 5278 2342214
Inappropriate antidiuretic hormone secretion 215.76 33.06 73 10520 2236 2345256
Diarrhoea 215.13 33.06 261 10332 83303 2264189
Akathisia 213.53 33.06 67 10526 1607 2345885
Muscle rigidity 207.62 33.06 67 10526 1764 2345728
Withdrawal syndrome 207.53 33.06 78 10515 3259 2344233
Hallucination 207.12 33.06 101 10492 8047 2339445
Drug ineffective 203.11 33.06 280 10313 101344 2246148
Temperature regulation disorder 199.95 33.06 40 10553 121 2347371
Palpitations 196.63 33.06 124 10469 16332 2331160
Feeling abnormal 187.25 33.06 138 10455 23443 2324049
Muscle twitching 184.26 33.06 68 10525 2697 2344795
Bruxism 175.25 33.06 48 10545 701 2346791
Lethargy 168.83 33.06 90 10503 8640 2338852
Atrial septal defect 168.11 33.06 53 10540 1291 2346201
Dyskinesia 164.03 33.06 73 10520 4716 2342776
Small for dates baby 161.90 33.06 44 10549 623 2346869
Pregnancy 159.51 33.06 84 10509 7865 2339627
Memory impairment 158.39 33.06 99 10494 12824 2334668
Coma scale abnormal 157.50 33.06 45 10548 773 2346719
Ventricular fibrillation 157.30 33.06 57 10536 2144 2345348
Decreased appetite 156.35 33.06 135 10458 28756 2318736
Irritability 155.33 33.06 77 10516 6350 2341142
Hypoglycaemia 152.30 33.06 83 10510 8324 2339168
Metabolic acidosis 151.33 33.06 74 10519 5924 2341568
Constipation 150.46 33.06 117 10476 21512 2325980
Long QT syndrome 149.42 33.06 40 10553 533 2346959
Galactorrhoea 145.08 33.06 47 10546 1252 2346240
Ventricular septal defect 144.43 33.06 42 10551 770 2346722
Rhabdomyolysis 143.53 33.06 74 10519 6630 2340862
Dry mouth 142.66 33.06 79 10514 8174 2339318
Psychomotor hyperactivity 141.94 33.06 51 10542 1871 2345621
Drug withdrawal syndrome 139.46 33.06 73 10520 6748 2340744
Hypertension 138.28 33.06 123 10470 27238 2320254
Circulatory collapse 138.04 33.06 60 10533 3660 2343832
Abnormal behaviour 136.09 33.06 64 10529 4696 2342796
Haematemesis 135.87 33.06 61 10532 4021 2343471
Gait disturbance 135.60 33.06 112 10481 22433 2325059
Visual impairment 133.92 33.06 86 10507 11669 2335823
Sinus tachycardia 131.16 33.06 56 10537 3269 2344223
Caesarean section 129.54 33.06 59 10534 4022 2343470
Maternal drugs affecting foetus 129.27 33.06 45 10548 1502 2345990
White blood cell count increased 128.52 33.06 70 10523 7008 2340484
Delirium 127.46 33.06 63 10530 5160 2342332
Depressed mood 124.77 33.06 62 10531 5136 2342356
Urinary retention 122.69 33.06 55 10538 3612 2343880
Pulseless electrical activity 122.68 33.06 39 10554 976 2346516
Weight increased 122.04 33.06 105 10488 22232 2325260
Hyperreflexia 118.81 33.06 37 10556 864 2346628
Angle closure glaucoma 117.07 33.06 35 10558 709 2346783
Hallucination, visual 116.93 33.06 50 10543 2929 2344563
Respiratory disorder neonatal 116.04 33.06 26 10567 153 2347339
Anorgasmia 115.97 33.06 27 10566 193 2347299
Extrapyramidal disorder 114.46 33.06 46 10547 2301 2345191
Brain injury 113.92 33.06 36 10557 883 2346609
Psychotic disorder 112.86 33.06 56 10537 4623 2342869
Asthenia 111.33 33.06 141 10452 46785 2300707
Maternal exposure during pregnancy 111.19 33.06 84 10509 14779 2332713
Pulmonary oedema 109.78 33.06 64 10529 7299 2340193
Food allergy 109.40 33.06 32 10561 599 2346893
Mania 109.32 33.06 45 10548 2395 2345097
Epilepsy 107.41 33.06 54 10539 4585 2342907
Selective eating disorder 106.15 33.06 28 10565 351 2347141
Cerebral vasoconstriction 105.92 33.06 27 10566 293 2347199
Abdominal pain 105.80 33.06 118 10475 34256 2313236
Myocardial stunning 105.44 33.06 19 10574 25 2347467
Respiratory failure 104.62 33.06 78 10515 13450 2334042
Crying 104.22 33.06 52 10541 4344 2343148
Drug level increased 103.55 33.06 45 10548 2742 2344750
Paraesthesia 103.09 33.06 95 10498 21993 2325499
Alcoholism 102.84 33.06 27 10566 332 2347160
Amnesia 102.76 33.06 61 10532 7192 2340300
Cognitive disorder 99.85 33.06 54 10539 5327 2342165
Hypersensitivity 99.64 33.06 96 10497 23497 2323995
Arrhythmia 99.51 33.06 56 10537 5972 2341520
Pain 99.19 33.06 154 10439 61703 2285789
Vision blurred 99.01 33.06 78 10515 14590 2332902
Sleep disorder 98.31 33.06 57 10536 6432 2341060
Product prescribing error 97.75 33.06 44 10549 2916 2344576
Coeliac disease 96.56 33.06 31 10562 801 2346691
Blood sodium decreased 95.80 33.06 44 10549 3056 2344436
Sedation 95.46 33.06 45 10548 3317 2344175
Alcohol use 94.96 33.06 27 10566 455 2347037
Liver injury 94.66 33.06 40 10553 2274 2345218
Self-injurious ideation 94.65 33.06 28 10565 546 2346946
Dysarthria 94.53 33.06 55 10538 6247 2341245
Dystonia 93.34 33.06 39 10554 2155 2345337
Hypoaesthesia 92.49 33.06 86 10507 20129 2327363
Heart rate increased 90.29 33.06 66 10527 11039 2336453
Product substitution issue 88.88 33.06 49 10544 5020 2342472
Nightmare 88.42 33.06 44 10549 3653 2343839
Gestational diabetes 88.30 33.06 33 10560 1354 2346138
Weight decreased 88.30 33.06 98 10495 28273 2319219
Loss of libido 88.26 33.06 23 10570 274 2347218
Hallucination, auditory 86.71 33.06 37 10556 2155 2345337
Major depression 85.89 33.06 30 10563 1011 2346481
Blood creatine phosphokinase increased 85.55 33.06 48 10545 5088 2342404
Visual field defect 85.45 33.06 33 10560 1483 2346009
Immunodeficiency 84.92 33.06 30 10563 1046 2346446
Balance disorder 83.96 33.06 60 10533 9687 2337805
Acidosis 83.52 33.06 33 10560 1577 2345915
Pupillary reflex impaired 82.77 33.06 24 10569 435 2347057
Alcohol abuse 81.69 33.06 22 10571 300 2347192
Ventricular extrasystoles 80.47 33.06 34 10559 1932 2345560
Talipes 79.41 33.06 21 10572 266 2347226
Hyperthermia 79.35 33.06 31 10562 1437 2346055
Impulsive behaviour 78.67 33.06 22 10571 348 2347144
Mood swings 78.46 33.06 39 10554 3230 2344262
Hypotonia neonatal 78.45 33.06 20 10573 217 2347275
Paranoia 78.20 33.06 34 10559 2073 2345419
Bursitis 78.10 33.06 33 10560 1875 2345617
Drug intolerance 77.96 33.06 66 10527 13651 2333841
Hypochloraemia 77.34 33.06 21 10572 296 2347196
Abortion induced 76.62 33.06 39 10554 3397 2344095
Clonus 76.04 33.06 24 10569 586 2346906
Catatonia 75.95 33.06 26 10567 824 2346668
Photophobia 75.50 33.06 34 10559 2255 2345237
Alcohol interaction 75.08 33.06 20 10573 261 2347231
Aspiration 74.56 33.06 30 10563 1504 2345988
Obsessive-compulsive disorder 73.89 33.06 24 10569 644 2346848
Platelet count increased 73.06 33.06 33 10560 2204 2345288
Restless legs syndrome 72.58 33.06 33 10560 2238 2345254
Posturing 72.36 33.06 17 10576 127 2347365
Nervousness 71.82 33.06 43 10550 5146 2342346
Parkinsonism 71.66 33.06 29 10564 1476 2346016
Yawning 71.49 33.06 18 10575 185 2347307
Contusion 71.49 33.06 61 10532 12749 2334743
Physical assault 71.32 33.06 18 10575 187 2347305
Loss of personal independence in daily activities 70.89 33.06 43 10550 5268 2342224
Cardiotoxicity 69.77 33.06 27 10566 1220 2346272
Tearfulness 69.66 33.06 25 10568 913 2346579
Asthma 69.60 33.06 57 10536 11257 2336235
Respiratory acidosis 69.04 33.06 24 10569 797 2346695
Gastrointestinal haemorrhage 68.95 33.06 59 10534 12376 2335116
Chills 68.88 33.06 65 10528 15487 2332005
Nystagmus 68.16 33.06 26 10567 1129 2346363
Hypothermia 67.97 33.06 31 10562 2117 2345375
Accidental death 67.97 33.06 19 10574 300 2347192
Urinary tract infection 67.80 33.06 88 10505 29854 2317638
Anaemia 67.74 33.06 95 10498 34697 2312795
Thinking abnormal 67.74 33.06 30 10563 1912 2345580
Ventricular arrhythmia 67.57 33.06 22 10571 595 2346897
Illness anxiety disorder 67.55 33.06 14 10579 53 2347439
Hepatic steatosis 67.39 33.06 35 10558 3178 2344314
Hypokinesia 67.37 33.06 29 10564 1725 2345767
Acute kidney injury 67.37 33.06 85 10508 28037 2319455
Alcohol poisoning 66.55 33.06 19 10574 325 2347167
Bradyphrenia 65.80 33.06 25 10568 1074 2346418
Neonatal respiratory distress syndrome 65.24 33.06 21 10572 547 2346945
Haematoma 64.62 33.06 40 10553 5081 2342411
Asphyxia 64.32 33.06 24 10569 980 2346512
Poisoning deliberate 63.84 33.06 25 10568 1166 2346326
Neutrophil count increased 63.65 33.06 29 10564 1976 2345516
Anger 63.41 33.06 31 10562 2476 2345016
Areflexia 63.34 33.06 21 10572 602 2346890
Subdural haemorrhage 63.18 33.06 20 10573 493 2346999
Miosis 63.18 33.06 25 10568 1199 2346293
Drug level above therapeutic 62.88 33.06 20 10573 501 2346991
Libido decreased 62.50 33.06 20 10573 511 2346981
Blood pressure decreased 62.05 33.06 49 10544 9187 2338305
Antidepressant drug level above therapeutic 61.57 33.06 13 10580 55 2347437
Obsessive thoughts 61.52 33.06 16 10577 189 2347303
Pruritus 61.27 33.06 102 10491 43238 2304254
Parkinson's disease 61.24 33.06 25 10568 1301 2346191
Product complaint 61.23 33.06 37 10556 4501 2342991
Dissociation 61.18 33.06 19 10574 439 2347053
Apathy 60.86 33.06 25 10568 1322 2346170
Tachypnoea 60.71 33.06 29 10564 2200 2345292
Blood pressure increased 60.41 33.06 63 10530 16923 2330569
Stress 60.41 33.06 43 10550 6895 2340597
Prescribed overdose 59.85 33.06 27 10566 1797 2345695
Optic ischaemic neuropathy 59.75 33.06 17 10576 287 2347205
Delusion 59.72 33.06 28 10565 2037 2345455
Pneumonia aspiration 59.68 33.06 34 10559 3708 2343784
Orthostatic intolerance 59.50 33.06 15 10578 155 2347337
Fear 59.22 33.06 30 10563 2586 2344906
Mental status changes 59.02 33.06 39 10554 5543 2341949
Premature baby 59.00 33.06 32 10561 3172 2344320
Rash erythematous 58.97 33.06 40 10553 5936 2341556
General physical health deterioration 58.64 33.06 57 10536 14082 2333410
Potentiating drug interaction 58.47 33.06 20 10573 632 2346860
Multiple fractures 58.38 33.06 20 10573 635 2346857
International normalised ratio increased 58.25 33.06 43 10550 7293 2340199
Vaginal haemorrhage 58.07 33.06 37 10556 4943 2342549
Wound 58.03 33.06 30 10563 2698 2344794
Product administration error 58.03 33.06 34 10559 3909 2343583
Hypotonia 58.01 33.06 26 10567 1704 2345788
Heart rate decreased 57.55 33.06 33 10560 3643 2343849
Vertigo 57.13 33.06 47 10546 9337 2338155
Electrolyte imbalance 57.00 33.06 27 10566 2010 2345482
Hepatitis 56.85 33.06 40 10553 6297 2341195
Toxicologic test abnormal 56.22 33.06 14 10579 137 2347355
Speech disorder 56.13 33.06 40 10553 6424 2341068
Bradykinesia 55.80 33.06 19 10574 592 2346900
Congenital thrombocytopenia 55.69 33.06 9 10584 2 2347490
Muscle tightness 55.62 33.06 26 10567 1879 2345613
Haemoglobin decreased 55.23 33.06 62 10531 18089 2329403
Abnormal dreams 55.09 33.06 28 10565 2430 2345062
Pre-eclampsia 54.93 33.06 24 10569 1480 2346012
Treatment noncompliance 54.51 33.06 37 10556 5497 2341995
Muscular weakness 54.31 33.06 56 10537 14841 2332651
Polyhydramnios 53.74 33.06 16 10577 319 2347173
Haemodynamic instability 53.67 33.06 22 10571 1157 2346335
Dyspnoea 53.65 33.06 137 10456 78596 2268896
Urinary incontinence 53.24 33.06 33 10560 4200 2343292
Gastrointestinal sounds abnormal 52.98 33.06 18 10575 557 2346935
Gastrointestinal disorder 52.90 33.06 44 10549 8873 2338619
Pupil fixed 52.88 33.06 17 10576 441 2347051
Hypertonia 52.77 33.06 22 10571 1208 2346284
Psychomotor retardation 52.74 33.06 18 10575 565 2346927
Trismus 52.57 33.06 20 10573 862 2346630
Foetal death 52.45 33.06 25 10568 1887 2345605
Contraindicated product administered 52.39 33.06 29 10564 2992 2344500
Homicidal ideation 52.24 33.06 17 10576 459 2347033
Mood altered 52.16 33.06 28 10565 2718 2344774
Wheezing 52.00 33.06 38 10555 6346 2341146
Cardiogenic shock 51.85 33.06 27 10566 2464 2345028
Alanine aminotransferase increased 51.61 33.06 53 10540 13979 2333513
Burning sensation 51.44 33.06 41 10552 7787 2339705
Postmortem blood drug level increased 51.28 33.06 11 10582 51 2347441
Dehydration 51.18 33.06 66 10527 22229 2325263
Neuropathy, ataxia, retinitis pigmentosa syndrome 51.10 33.06 8 10585 0 2347492
Body temperature increased 51.07 33.06 29 10564 3142 2344350
Brain oedema 50.86 33.06 26 10567 2284 2345208
Neuroleptic malignant syndrome 50.45 33.06 25 10568 2055 2345437
Abdominal pain upper 50.07 33.06 65 10528 22035 2325457
Head injury 49.60 33.06 31 10562 4003 2343489
Hyperprolactinaemia 48.97 33.06 18 10575 704 2346788
Drug withdrawal syndrome neonatal 48.85 33.06 16 10577 441 2347051
Fluid retention 48.66 33.06 38 10555 7008 2340484
Hypoxia 48.32 33.06 36 10557 6191 2341301
Rectal haemorrhage 48.02 33.06 35 10558 5821 2341671
Personality change 47.80 33.06 19 10574 922 2346570
Cerebral haemorrhage 47.65 33.06 34 10559 5470 2342022
Pain in jaw 47.58 33.06 36 10557 6336 2341156
Skin laceration 47.20 33.06 26 10567 2656 2344836
Aspartate aminotransferase increased 47.04 33.06 48 10545 12564 2334928
Hypomania 47.02 33.06 18 10575 789 2346703
Mutism 46.98 33.06 14 10579 280 2347212
Hepatocellular injury 46.96 33.06 30 10563 4025 2343467
Abnormal weight gain 46.94 33.06 14 10579 281 2347211
Suicidal behaviour 46.79 33.06 16 10577 505 2346987
Osmotic demyelination syndrome 46.35 33.06 12 10581 139 2347353
Disinhibition 45.39 33.06 13 10580 225 2347267
Neutrophil count abnormal 45.17 33.06 15 10578 432 2347060
Muscle spasms 45.11 33.06 61 10532 21505 2325987
Chest pain 44.89 33.06 70 10523 28067 2319425
Mental disorder 44.81 33.06 29 10564 3978 2343514
Pyrexia 44.65 33.06 101 10492 53607 2293885
Self-medication 44.61 33.06 16 10577 583 2346909
Hypoxic-ischaemic encephalopathy 44.20 33.06 17 10576 755 2346737
Drug dependence 44.13 33.06 26 10567 3019 2344473
Facial paralysis 44.09 33.06 24 10569 2395 2345097
Congenital pulmonary valve atresia 44.08 33.06 9 10584 31 2347461
Rabbit syndrome 44.04 33.06 10 10583 63 2347429
Off label use 43.96 33.06 122 10471 73476 2274016
Hepatic enzyme increased 43.44 33.06 41 10552 9761 2337731
Bradycardia neonatal 43.43 33.06 12 10581 181 2347311
Borderline personality disorder 43.43 33.06 11 10582 116 2347376
Movement disorder 43.24 33.06 25 10568 2803 2344689
Trisomy 18 42.83 33.06 9 10584 37 2347455
Patent ductus arteriosus 42.77 33.06 16 10577 658 2346834
Peritonitis 42.70 33.06 24 10569 2550 2344942
Anticholinergic syndrome 42.59 33.06 13 10580 283 2347209
Oesophagitis 42.49 33.06 22 10571 1984 2345508
Acute respiratory distress syndrome 42.25 33.06 26 10567 3266 2344226
Infantile apnoea 42.21 33.06 12 10581 202 2347290
Hepatic failure 42.16 33.06 32 10561 5657 2341835
Psychiatric symptom 41.93 33.06 17 10576 869 2346623
Adrenergic syndrome 41.55 33.06 7 10586 4 2347488
Incoherent 41.40 33.06 17 10576 898 2346594
Product use issue 41.23 33.06 44 10549 12125 2335367
Hippocampal sclerosis 41.09 33.06 8 10585 20 2347472
Histrionic personality disorder 41.09 33.06 8 10585 20 2347472
Abortion spontaneous 41.01 33.06 46 10547 13399 2334093
Meconium in amniotic fluid 41.01 33.06 10 10583 89 2347403
Panic reaction 40.36 33.06 16 10577 771 2346721
Appetite disorder 39.98 33.06 15 10578 622 2346870
Merycism 39.54 33.06 8 10585 26 2347466
Aphasia 39.37 33.06 29 10564 4899 2342593
Melaena 39.36 33.06 27 10566 4079 2343413
Musculoskeletal stiffness 39.25 33.06 43 10550 12204 2335288
Migraine 38.73 33.06 40 10553 10613 2336879
Feeling hot 38.65 33.06 33 10560 6895 2340597
Anuria 38.62 33.06 20 10573 1804 2345688
Deafness neurosensory 38.60 33.06 14 10579 527 2346965
Substance abuse 38.40 33.06 14 10579 535 2346957
Tension 38.35 33.06 14 10579 537 2346955
Rheumatoid arthritis 38.30 33.06 53 10540 19087 2328405
Autonomic nervous system imbalance 38.21 33.06 13 10580 404 2347088
Status epilepticus 38.13 33.06 22 10571 2456 2345036
Therapy non-responder 38.03 33.06 35 10558 8069 2339423
Drug screen positive 37.94 33.06 16 10577 904 2346588
Rash 37.81 33.06 101 10492 59457 2288035
Blood potassium decreased 37.47 33.06 29 10564 5276 2342216
Lower respiratory tract infection 36.90 33.06 29 10564 5395 2342097
Cerebrospinal fluid retention 36.40 33.06 7 10586 16 2347476
Oedema peripheral 36.34 33.06 58 10535 23705 2323787
Altered state of consciousness 36.10 33.06 25 10568 3835 2343657
Labelled drug-drug interaction medication error 35.57 33.06 17 10576 1291 2346201
Anxiety disorder 35.52 33.06 13 10580 502 2346990
Neonatal hypoxia 35.52 33.06 9 10584 95 2347397
Female sexual arousal disorder 35.28 33.06 7 10586 20 2347472
Orgasm abnormal 34.88 33.06 8 10585 53 2347439
Left ventricular hypertrophy 34.88 33.06 14 10579 697 2346795
Hypomagnesaemia 34.83 33.06 21 10572 2543 2344949
Hyperkalaemia 34.78 33.06 29 10564 5864 2341628
Encephalopathy 34.56 33.06 26 10567 4535 2342957
Pulmonary congestion 34.44 33.06 19 10574 1946 2345546
Abdominal discomfort 34.42 33.06 48 10545 17408 2330084
Disturbance in sexual arousal 34.38 33.06 8 10585 57 2347435
Pupils unequal 34.37 33.06 11 10582 281 2347211
Antipsychotic drug level increased 34.26 33.06 13 10580 556 2346936
Increased appetite 34.01 33.06 17 10576 1423 2346069
Narcolepsy 33.94 33.06 10 10583 192 2347300
Erythema 33.89 33.06 58 10535 25101 2322391
Apgar score low 33.84 33.06 10 10583 194 2347298
Hypersomnia 33.75 33.06 20 10573 2346 2345146
Myocardial fibrosis 33.60 33.06 9 10584 120 2347372
Cardiomegaly 33.52 33.06 20 10573 2376 2345116
Hyperventilation 33.50 33.06 16 10577 1213 2346279
Nervous system disorder 33.49 33.06 22 10571 3094 2344398
Hallucinations, mixed 33.45 33.06 13 10580 594 2346898
Ischaemia 33.42 33.06 14 10579 778 2346714
Haematochezia 33.22 33.06 27 10566 5268 2342224
Premature labour 33.21 33.06 19 10574 2087 2345405
Extrasystoles 33.16 33.06 15 10578 1004 2346488
Renal failure 33.16 33.06 47 10546 17302 2330190

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Completed suicide 3265.59 38.01 915 5623 15397 1724846
Toxicity to various agents 3228.51 38.01 1033 5505 28108 1712135
Drug abuse 1971.06 38.01 598 5940 13091 1727152
Serotonin syndrome 1126.45 38.01 276 6262 2512 1737731
Drug interaction 941.03 38.01 420 6118 27538 1712705
Overdose 898.52 38.01 351 6187 16350 1723893
Intentional overdose 773.19 38.01 257 6281 7413 1732830
Foetal exposure during pregnancy 676.26 38.01 222 6316 6137 1734106
Cardio-respiratory arrest 653.06 38.01 238 6300 9055 1731188
Suicide attempt 536.61 38.01 194 6344 7187 1733056
Cardiac arrest 522.45 38.01 236 6302 15694 1724549
Respiratory arrest 490.78 38.01 171 6367 5668 1734575
Electrocardiogram QT prolonged 479.94 38.01 166 6372 5379 1734864
Poisoning 471.16 38.01 136 6402 2396 1737847
Anxiety 370.44 38.01 185 6353 15342 1724901
Confusional state 353.29 38.01 199 6339 21079 1719164
Intentional product misuse 335.87 38.01 138 6400 7220 1733023
Suicidal ideation 316.38 38.01 138 6400 8380 1731863
Tremor 311.63 38.01 156 6382 12975 1727268
Agitation 309.67 38.01 147 6391 10879 1729364
Hyponatraemia 309.09 38.01 138 6400 8862 1731381
Restlessness 303.86 38.01 111 6427 4210 1736033
Death 293.75 38.01 315 6223 87128 1653115
Tachycardia 290.72 38.01 147 6391 12481 1727762
Neonatal respiratory distress syndrome 283.37 38.01 72 6466 757 1739486
Fall 278.63 38.01 187 6351 27027 1713216
Depression 276.60 38.01 156 6382 16513 1723730
Respiratory disorder neonatal 266.22 38.01 56 6482 227 1740016
Intentional self-injury 266.09 38.01 89 6449 2584 1737659
Atrial septal defect 248.16 38.01 72 6466 1286 1738957
Asphyxia 236.54 38.01 66 6472 1017 1739226
Somnolence 230.84 38.01 139 6399 16600 1723643
Aggression 230.10 38.01 109 6429 8006 1732237
Agitation neonatal 221.38 38.01 47 6491 201 1740042
Drug withdrawal syndrome neonatal 216.72 38.01 56 6482 632 1739611
Exposure during pregnancy 203.99 38.01 74 6464 2743 1737500
Disturbance in attention 201.79 38.01 82 6456 4152 1736091
Depressed level of consciousness 200.58 38.01 93 6445 6499 1733744
Loss of consciousness 190.82 38.01 118 6420 14757 1725486
Erectile dysfunction 183.61 38.01 78 6460 4419 1735824
Hypotension 177.85 38.01 148 6390 29506 1710737
Bradycardia 175.54 38.01 99 6439 10435 1729808
Hyperhidrosis 172.75 38.01 104 6434 12384 1727859
Maternal drugs affecting foetus 165.80 38.01 51 6487 1120 1739123
Small for dates baby 165.62 38.01 44 6494 557 1739686
Hypospadias 157.48 38.01 42 6496 540 1739703
Metabolic acidosis 157.42 38.01 74 6464 5328 1734915
Irritability 155.74 38.01 74 6464 5458 1734785
Condition aggravated 144.48 38.01 114 6424 21036 1719207
Mydriasis 143.33 38.01 47 6491 1277 1738966
Muscle rigidity 142.96 38.01 51 6487 1797 1738446
Insomnia 142.92 38.01 102 6436 16174 1724069
Sopor 142.71 38.01 52 6486 1949 1738294
Seizure 141.39 38.01 111 6427 20330 1719913
Hypertonia neonatal 140.08 38.01 28 6510 82 1740161
Cryptorchism 136.26 38.01 34 6504 329 1739914
Inappropriate antidiuretic hormone secretion 134.30 38.01 48 6490 1700 1738543
Hyperreflexia 131.70 38.01 37 6501 584 1739659
Coma 128.38 38.01 71 6467 7191 1733052
Unresponsive to stimuli 127.46 38.01 61 6477 4568 1735675
Sexual dysfunction 121.22 38.01 45 6493 1778 1738465
Bradycardia neonatal 119.99 38.01 28 6510 198 1740045
Drug ineffective 119.15 38.01 172 6366 63629 1676614
Myoclonus 118.08 38.01 47 6491 2248 1737995
Pulmonary oedema 115.33 38.01 64 6474 6522 1733721
Neonatal seizure 114.51 38.01 25 6513 125 1740118
Premature baby 113.33 38.01 49 6489 2893 1737350
Disorientation 109.25 38.01 58 6480 5411 1734832
Torsade de pointes 107.94 38.01 38 6500 1286 1738957
Electrocardiogram QRS complex prolonged 106.51 38.01 33 6505 742 1739501
Mental status changes 103.53 38.01 58 6480 6017 1734226
Asthenia 103.28 38.01 118 6420 34552 1705691
Dizziness 102.45 38.01 117 6421 34244 1705999
Mental impairment 96.62 38.01 39 6499 1934 1738309
Psychotic disorder 96.43 38.01 52 6486 5004 1735239
Hallucination 95.02 38.01 61 6477 8109 1732134
Accidental death 93.51 38.01 26 6512 394 1739849
Depressed mood 93.02 38.01 43 6495 2973 1737270
Drug screen positive 92.55 38.01 32 6506 1025 1739218
Dyskinesia 92.14 38.01 46 6492 3773 1736470
Temperature regulation disorder 91.45 38.01 21 6517 137 1740106
Alcohol use 91.24 38.01 30 6508 821 1739422
Generalised tonic-clonic seizure 89.63 38.01 46 6492 4000 1736243
Muscle twitching 89.55 38.01 36 6502 1766 1738477
Rhabdomyolysis 89.27 38.01 66 6472 11024 1729219
Withdrawal syndrome 87.76 38.01 38 6500 2250 1737993
Hypoglycaemia neonatal 86.55 38.01 23 6515 291 1739952
Hyperbilirubinaemia neonatal 85.74 38.01 19 6519 103 1740140
Conduction disorder 85.69 38.01 24 6514 374 1739869
Logorrhoea 84.93 38.01 25 6513 469 1739774
Sedation 84.92 38.01 42 6496 3375 1736868
Haemangioma congenital 84.36 38.01 18 6520 79 1740164
Fatigue 81.86 38.01 128 6410 50653 1689590
Myocardial fibrosis 81.09 38.01 19 6519 137 1740106
Mania 80.41 38.01 35 6503 2098 1738145
Arrhythmia 80.21 38.01 49 6489 5967 1734276
Disinhibition 79.83 38.01 22 6516 322 1739921
Vomiting 78.22 38.01 108 6430 38207 1702036
Patent ductus arteriosus 77.09 38.01 25 6513 654 1739589
Infantile apnoea 76.69 38.01 20 6518 234 1740009
Brain oedema 76.22 38.01 34 6504 2162 1738081
Amnesia 76.06 38.01 44 6494 4847 1735396
Coma scale abnormal 76.00 38.01 24 6514 575 1739668
Apathy 75.32 38.01 29 6509 1267 1738976
Akathisia 74.63 38.01 29 6509 1299 1738944
Exposure via ingestion 73.01 38.01 24 6514 656 1739587
Gun shot wound 72.94 38.01 21 6517 363 1739880
Circulatory collapse 72.70 38.01 38 6500 3429 1736814
Sleep disorder 72.50 38.01 40 6498 4023 1736220
Lethargy 72.25 38.01 49 6489 7135 1733108
Homicide 71.38 38.01 20 6518 312 1739931
Caesarean section 71.28 38.01 23 6515 592 1739651
Feeling abnormal 69.32 38.01 57 6481 11109 1729134
Clonus 68.67 38.01 21 6517 451 1739792
Cardiotoxicity 68.38 38.01 24 6514 804 1739439
Dysarthria 67.97 38.01 42 6496 5217 1735026
Somnambulism 67.91 38.01 23 6515 691 1739552
Delirium 67.83 38.01 45 6493 6317 1733926
Substance abuse 67.54 38.01 25 6513 978 1739265
Loss of libido 67.47 38.01 23 6515 705 1739538
Selective eating disorder 66.69 38.01 20 6518 401 1739842
Alcohol interaction 66.57 38.01 19 6519 318 1739925
Headache 65.81 38.01 94 6444 34282 1705961
Syncope 65.20 38.01 61 6477 14108 1726135
Obsessive-compulsive disorder 64.57 38.01 23 6515 805 1739438
Nausea 63.71 38.01 115 6423 51081 1689162
Memory impairment 63.57 38.01 44 6494 6619 1733624
Congenital central nervous system anomaly 63.20 38.01 15 6523 115 1740128
Apgar score low 63.12 38.01 17 6521 227 1740016
Blood creatine phosphokinase increased 63.05 38.01 49 6489 8807 1731436
Drug level increased 62.72 38.01 32 6506 2745 1737498
Ventricular septal defect 62.14 38.01 22 6516 756 1739487
Panic attack 62.12 38.01 28 6510 1824 1738419
Gait disturbance 61.10 38.01 56 6482 12614 1727629
Abnormal behaviour 60.79 38.01 42 6496 6300 1733943
Tardive dyskinesia 60.66 38.01 24 6514 1128 1739115
Maternal exposure during breast feeding 59.14 38.01 18 6520 380 1739863
Psychomotor hyperactivity 58.39 38.01 27 6511 1866 1738377
Impulsive behaviour 58.30 38.01 19 6519 505 1739738
Cognitive disorder 57.01 38.01 35 6503 4295 1735948
Hypertonia 56.52 38.01 24 6514 1353 1738890
Hydrocele 56.49 38.01 17 6521 345 1739898
Toxicologic test abnormal 56.23 38.01 14 6524 134 1740109
Accidental overdose 55.70 38.01 34 6504 4130 1736113
Arteriosclerosis coronary artery 55.30 38.01 26 6512 1866 1738377
Heart rate increased 55.18 38.01 40 6498 6470 1733773
Libido decreased 54.07 38.01 23 6515 1302 1738941
Prescribed overdose 53.83 38.01 25 6513 1745 1738498
Mental disorder 53.51 38.01 29 6509 2814 1737429
Hypomania 53.22 38.01 18 6520 538 1739705
Drug withdrawal syndrome 53.10 38.01 34 6504 4491 1735752
Hypertension 52.44 38.01 63 6475 19385 1720858
Anger 52.43 38.01 28 6510 2638 1737605
Cerebral haemorrhage 51.91 38.01 38 6500 6239 1734004
Vasoplegia syndrome 51.90 38.01 14 6524 188 1740055
Oesophageal perforation 51.88 38.01 13 6525 128 1740115
Decreased interest 51.44 38.01 16 6522 364 1739879
Newborn persistent pulmonary hypertension 51.08 38.01 9 6529 9 1740234
Speech disorder 50.48 38.01 33 6505 4515 1735728
Long QT syndrome 49.86 38.01 15 6523 304 1739939
Product prescribing error 49.34 38.01 26 6512 2384 1737859
Antipsychotic drug level increased 49.25 38.01 18 6520 679 1739564
Vestibular disorder 48.73 38.01 13 6525 167 1740076
Neonatal disorder 48.53 38.01 15 6523 334 1739909
Panic reaction 48.19 38.01 15 6523 342 1739901
Neuroleptic malignant syndrome 48.08 38.01 28 6510 3120 1737123
Tic 47.87 38.01 18 6520 736 1739507
Hallucination, visual 47.56 38.01 26 6512 2566 1737677
Poverty of speech 47.22 38.01 10 6528 42 1740201
Product substitution issue 46.96 38.01 28 6510 3258 1736985
Parkinsonism 46.87 38.01 21 6517 1348 1738895
Alcoholism 46.12 38.01 16 6522 517 1739726
Paranoia 45.99 38.01 24 6514 2157 1738086
Tearfulness 45.98 38.01 14 6524 296 1739947
Nightmare 45.80 38.01 26 6512 2761 1737482
Respiratory acidosis 45.78 38.01 17 6521 671 1739572
Subdural haematoma 45.65 38.01 28 6510 3429 1736814
Coordination abnormal 45.07 38.01 21 6517 1476 1738767
Psychomotor skills impaired 44.11 38.01 14 6524 341 1739902
Bipolar disorder 44.09 38.01 17 6521 745 1739498
Malaise 44.02 38.01 72 6466 29493 1710750
Palpitations 42.71 38.01 35 6503 6779 1733464
Sinus tachycardia 42.63 38.01 24 6514 2508 1737735
Hypokalaemia 42.62 38.01 34 6504 6340 1733903
Incontinence 42.49 38.01 18 6520 1008 1739235
Poor feeding infant 42.44 38.01 10 6528 74 1740169
Euphoric mood 42.38 38.01 17 6521 828 1739415
Large for dates baby 42.23 38.01 11 6527 128 1740115
Mood swings 42.12 38.01 22 6516 1980 1738263
Duodenal ulcer perforation 41.74 38.01 13 6525 297 1739946
Hallucination, auditory 40.97 38.01 22 6516 2095 1738148
Paraesthesia 40.55 38.01 41 6497 10410 1729833
Alanine aminotransferase increased 40.21 38.01 44 6494 12234 1728009
Increased appetite 40.10 38.01 17 6521 954 1739289
Aspartate aminotransferase increased 39.56 38.01 41 6497 10715 1729528
Depressive symptom 39.45 38.01 13 6525 358 1739885
Sudden death 39.30 38.01 24 6514 2916 1737327
Dystonia 39.17 38.01 21 6517 1993 1738250
Slow response to stimuli 38.94 38.01 11 6527 177 1740066
Anorgasmia 38.15 38.01 11 6527 191 1740052
Hypoxia 38.15 38.01 31 6507 5932 1734311

Pharmacologic Action:

SourceCodeDescription
ATC N06AB04 NERVOUS SYSTEM
PSYCHOANALEPTICS
ANTIDEPRESSANTS
Selective serotonin reuptake inhibitors
FDA EPC N0000175696 Serotonin Reuptake Inhibitor
CHEBI has role CHEBI:50949 serotonin uptake inhibitor
CHEBI has role CHEBI:35469 antidepressant
MeSH PA D000928 Antidepressive Agents
MeSH PA D018687 Antidepressive Agents, Second-Generation
MeSH PA D002491 Central Nervous System Agents
MeSH PA D049990 Membrane Transport Modulators
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D014179 Neurotransmitter Uptake Inhibitors
MeSH PA D011619 Psychotropic Drugs
MeSH PA D018490 Serotonin Agents
MeSH PA D017367 Serotonin Uptake Inhibitors

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Generalized anxiety disorder indication 21897009 DOID:14320
Depressive disorder indication 35489007
Major depressive disorder indication 370143000
Posttraumatic stress disorder off-label use 47505003 DOID:2055
Bipolar affective disorder, current episode depression off-label use 191627008 DOID:3312
Obsessive-compulsive disorder off-label use 191736004 DOID:10933
Menopausal flushing off-label use 198436008
Panic disorder off-label use 371631005 DOID:594
Suicidal thoughts contraindication 6471006
Bipolar disorder contraindication 13746004 DOID:3312
Neuroleptic malignant syndrome contraindication 15244003 DOID:14464
Torsades de pointes contraindication 31722008
Upper gastrointestinal hemorrhage contraindication 37372002
Hypokalemia contraindication 43339004
Chronic heart failure contraindication 48447003
Bradycardia contraindication 48867003
Syndrome of inappropriate vasopressin secretion contraindication 55004003 DOID:3401
Heart disease contraindication 56265001 DOID:114
Acute nephropathy contraindication 58574008
Blood coagulation disorder contraindication 64779008 DOID:1247
Epilepsy contraindication 84757009 DOID:1826
Hyponatremia contraindication 89627008
Prolonged QT interval contraindication 111975006
Hypomagnesemia contraindication 190855004
Disease of liver contraindication 235856003 DOID:409
Serotonin syndrome contraindication 371089000
Myocardial infarction in recovery phase contraindication 418044006
Poor metabolizer due to cytochrome p450 CYP2C19 variant contraindication 424500005
Congenital long QT syndrome contraindication 442917000

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.33 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Sodium-dependent serotonin transporter Transporter INHIBITOR Kd 8.94 WOMBAT-PK CHEMBL
Sigma non-opioid intracellular receptor 1 Membrane receptor Ki 6.78 DRUG MATRIX
5-hydroxytryptamine receptor 2B GPCR Ki 5.93 DRUG MATRIX
Alpha-1D adrenergic receptor GPCR Ki 6.15 DRUG MATRIX
Solute carrier family 22 member 1 Transporter IC50 4.73 CHEMBL
Sodium-dependent noradrenaline transporter Transporter Ki 5.21 CHEMBL
5-hydroxytryptamine receptor 2C GPCR Ki 6.21 WOMBAT-PK
Histamine H1 receptor GPCR Ki 6.46 WOMBAT-PK
Potassium voltage-gated channel subfamily H member 2 Ion channel IC50 5.40 WOMBAT-PK
Sodium-dependent dopamine transporter Transporter Ki 4.78 CHEMBL
5-hydroxytryptamine receptor 2A GPCR Ki 5.19 PDSP
Muscarinic acetylcholine receptor M1 GPCR Ki 5.88 PDSP
Alpha-1B adrenergic receptor GPCR Ki 5.74 DRUG MATRIX
Sodium-dependent serotonin transporter Transporter Ki 8.82 CHEMBL
Transporter Transporter Ki 5.23 CHEMBL
Sodium-dependent dopamine transporter Transporter Ki 8.54 CHEMBL
Transporter Transporter Ki 5.21 CHEMBL
Sodium-dependent dopamine transporter Transporter Ki 5.03 CHEMBL
5-hydroxytryptamine receptor 1A GPCR Ki 4.30 CHEMBL
Alpha-1A adrenergic receptor GPCR IC50 5.76 CHEMBL

External reference:

IDSource
4021129 VUID
N0000148583 NUI
C0008845 UMLSCUI
D00822 KEGG_DRUG
0DHU5B8D6V UNII
4138 INN_ID
321986007 SNOMEDCT_US
4021129 VANDF
005106 NDDF
2556 RXNORM
372596005 SNOMEDCT_US
d04332 MMSL
CHEMBL549 ChEMBL_ID
CHEMBL399730 ChEMBL_ID
DB00215 DRUGBANK_ID
CHEMBL1200781 ChEMBL_ID
59729-32-7 SECONDARY_CAS_RN
CHEBI:3723 CHEBI
7547 IUPHAR_LIGAND_ID
2771 PUBCHEM_CID
D015283 MESH_DESCRIPTOR_UI

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0054-0062 SOLUTION 10 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0121-0848 SOLUTION 10 mg ORAL ANDA 16 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0121-1696 SOLUTION 20 mg ORAL ANDA 16 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0185-0371 TABLET, FILM COATED 10 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0185-0372 TABLET, FILM COATED 20 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0185-0373 TABLET, FILM COATED 40 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0378-6231 TABLET, FILM COATED 10 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0378-6232 TABLET, FILM COATED 20 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0378-6233 TABLET, FILM COATED 40 mg ORAL ANDA 15 sections
Celexa HUMAN PRESCRIPTION DRUG LABEL 1 0456-4010 TABLET, FILM COATED 10 mg ORAL NDA 15 sections
Celexa HUMAN PRESCRIPTION DRUG LABEL 1 0456-4020 TABLET, FILM COATED 20 mg ORAL NDA 15 sections
Celexa HUMAN PRESCRIPTION DRUG LABEL 1 0456-4040 TABLET, FILM COATED 40 mg ORAL NDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0615-6510 TABLET 10 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0615-6511 TABLET 20 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0615-6512 TABLET 40 mg ORAL ANDA 15 sections
Citalopram Hydrobromide HUMAN PRESCRIPTION DRUG LABEL 1 0615-7830 TABLET 10 mg ORAL ANDA 16 sections
Citalopram Hydrobromide HUMAN PRESCRIPTION DRUG LABEL 1 0615-7831 TABLET 20 mg ORAL ANDA 16 sections
Citalopram Hydrobromide HUMAN PRESCRIPTION DRUG LABEL 1 0615-7832 TABLET 40 mg ORAL ANDA 16 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0615-8022 TABLET, FILM COATED 10 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0615-8023 TABLET, FILM COATED 20 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0615-8141 TABLET, FILM COATED 40 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0713-4740 TABLET 10 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0713-4741 TABLET 20 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 0713-4742 TABLET 40 mg ORAL ANDA 15 sections
Citalopram Hydrobromide HUMAN PRESCRIPTION DRUG LABEL 1 0904-6084 TABLET 10 mg ORAL ANDA 16 sections
Citalopram Hydrobromide HUMAN PRESCRIPTION DRUG LABEL 1 0904-6085 TABLET 20 mg ORAL ANDA 16 sections
Citalopram Hydrobromide HUMAN PRESCRIPTION DRUG LABEL 1 0904-6086 TABLET 40 mg ORAL ANDA 16 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 10544-006 TABLET 20 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 10544-149 TABLET 20 mg ORAL ANDA 15 sections
Citalopram HUMAN PRESCRIPTION DRUG LABEL 1 10544-150 TABLET 40 mg ORAL ANDA 15 sections